Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Mapping Personality Traits to Genes
This study has been completed.
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001414
  Purpose

Previous research involving families, twins, and adoption all support the idea that there is a substantial heritable aspect to personality.

The goal of this research study is to determine how genetics influence heritable personality traits. The work will focus on how genetics affect the chemical messengers which brain cells use to communicate with each other (neurotransmitters).

The study involves collecting personality data and DNA samples from related individuals, primarily male siblings and female siblings, but also including parents. Genetic tests performed on these samples will continue to focus on variations in genes, which potentially effect brain neurotransmission.

This research has the potential to advance knowledge of genetic influences on human behavior that may be relevant both to normal personality and to psychopathology.


Condition
Mental Disorder

MedlinePlus related topics: Child Mental Health Mental Health
Drug Information available for: Phenylephrine Guaifenesin Naphazoline Naphazoline hydrochloride Oxymetazoline Oxymetazoline hydrochloride Phenylephrine hydrochloride Phenylpropanolamine Phenylpropanolamine hydrochloride
U.S. FDA Resources
Study Type: Observational
Official Title: Mapping Personality Traits to Genes

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 2400
Study Start Date: April 1994
Estimated Study Completion Date: June 2002
Detailed Description:

Building on family, twin and adoption studies suggesting that substantial aspects of personality are heritable, research under this protocol explores potential genetic influences on normal personality dimensions. We have previously reported associations between variation in neurotransmitter system genes and variation in personality traits, both across and within families, in a sample of the general population. This study involves collecting personality data and DNA samples from related individuals, primarily male siblings and female siblings, but also including parents. Genetic tests performed on these samples will continue to focus on variations in genes, which potentially affect brain neurotransmission. In some cases, participants are recontacted to specifically investigate whether identified variations in neurotransmitter system genes actually affect neurotransmission. Large population samples are needed in this research, particularly since a new epidemiologically standard population sample will be obtained. This research has the potential to advance knowledge of genetic influences on human behavior that may be relevant both to normal personality and to psychopathology.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Personality data and DNA samples will be collected from related individuals, primarily pairs of male and pairs of female siblings, but also including parents.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001414

Locations
United States, Maryland
National Institute of Mental Health (NIMH)
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Publications:
Study ID Numbers: 940122, 94-M-0122
Study First Received: November 3, 1999
Last Updated: March 3, 2008
ClinicalTrials.gov Identifier: NCT00001414  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Behavior Genetics
Normal Personality
Intelligence
Siblings
Sixteen Personality Factor Questionnaire
NEO-Personality Inventory (Revised)
X-Chromosome

Study placed in the following topic categories:
Naphazoline
Oxymetazoline
Guaifenesin
Phenylephrine
Mental Disorders
Phenylpropanolamine

ClinicalTrials.gov processed this record on January 15, 2009